Redesign Science Inc — Form D
Redesign Science Inc of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-07. The offering totals $2.4M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-07
- Form: D
- Accession: 0001790035-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $1.7M
- Remaining: $700K
- Investors: 9
- Date of first sale: 2019-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-350483
Issuer
- Name: Redesign Science Inc
- CIK: 0001790035
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 180 VARICK ST, NEW YORK, NY, 10014
- Phone: 6104057966
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Haotian William Li | Director | NEW YORK, NY |
| David William Rooklin | Director | NEW YORK, NY |
| Andrew Tucker Avorn | Executive Officer | New York, NY |
| David William Rooklin | Executive Officer | NEW YORK, NY |
| David Rooklin | Director | New York, NY |
| David Rooklin | Executive Officer | New York, NY |
| Ted Jing | Director | New York, NY |
| Haotian Li | Director | New York, NY |
| Andrew Avorn | Executive Officer | New York, NY |
Other filings by this issuer (1)
More